Bristol-Myers Squibb Escapes Investor Suit Over Clinical Trial
For the second and final time, a New York federal judge on Wednesday dismissed an investor suit against Bristol-Myers Squibb that alleged the pharmaceutical company hid information about patients in a...To view the full article, register now.
Already a subscriber? Click here to view full article